CLINICAL_TRIALS
trial_result
· 2015-12-31
Clinical Trial Update: IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation [Phase 2]
Summary
Phase 2 trial of incobotulinumtoxinA for focal cancer pain after surgery and/or radiation. The study was terminated and results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Pain | Phase 2 | Status: TERMINATED | Results posted: 2015-12-31